News
Académie suisse des sciences techniques SATW
‘In Switzerland, people prefer to put their money in the bank’: Julia Biwer on risk culture, virtual start-ups and Basel’s unspoken dependence on its location
A biotech company without a laboratory? What sounds like a contradiction is, for Abbmira Therapeutics, the smartest business model. The Basel-based start-up is developing a drug to treat cancer and relies entirely on external experts from the Basel life sciences cluster. In an interview with the SATW, Julia Biwer, COO and co-founder, discusses why this model works, why venture capital is hard to come by in Switzerland, and what this reveals about Switzerland’s culture of innovation.



